Satellos Bioscience Inc.
MSLE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421642
No open-market purchases or sales by Satellos Bioscience Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $59.6M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Satellos Bioscience Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −5 vs. Q1 2026
- Shares held
- 7.68M
- +87.4K (+1.2%) vs. Q1 2026
- Total value
- $59.6M
- +$16.8M (+39.2%) vs. Q1 2026
- New holders
- 2
- 6 more added
- Sold out
- 7
- 6 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MSLE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $59.6M |
| Q1 2026 | 31 | $45.9M |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Satellos Bioscience Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 19 | $143 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 315 | $2.48K | 0.00% | +315 | New |
| UBS Group AG | 781 | $6.07K | 0.00% | +753+2,689.3% | Added |
| Geode Capital Management, LLC | 11,907 | $92.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 15,863 | $124.0K | 0.00% | −382−2.4% | Reduced |
| China Universal Asset Management Co., Ltd. | 20,000 | $155.5K | 0.01% | +13,600+212.5% | Added |
| Morgan Stanley | 25,732 | $200.1K | 0.00% | +4,549+21.5% | Added |
| Citadel Advisors LLC | 67,738 | $526.7K | 0.00% | +25,246+59.4% | Added |
| Empery Asset Management, LP | 107,100 | $832.7K | 0.96% | −123,000−53.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 150,000 | $1.17M | 0.00% | −230,354−60.6% | Reduced |
| Millennium Management LLC | 152,768 | $1.19M | 0.00% | −145,665−48.8% | Reduced |
| AWM Investment Company, Inc. | 180,000 | $1.40M | 0.12% | +180,000 | New |
| ADAR1 Capital Management, LLC | 222,555 | $1.73M | 0.08% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 230,833 | $1.79M | 0.17% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 314,359 | $2.44M | 0.08% | −100,000−24.1% | Reduced |
| Saturn V Capital Management LLC | 350,000 | $2.72M | 0.39% | 00.0% | Unchanged |
| Avidity Partners Management LP | 387,769 | $3.01M | 0.48% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 475,000 | $3.69M | 0.08% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 491,624 | $3.72M | 2.83% | +391,624+391.6% | Added |
| Woodline Partners LP | 500,432 | $3.89M | 0.01% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 652,590 | $5.07M | 0.73% | +163,383+33.4% | Added |
| Point72 Asset Management, L.P. | 682,700 | $5.31M | 0.01% | −8,078−1.2% | Reduced |
| Vivo Capital, LLC | 813,666 | $6.33M | 0.58% | 00.0% | Unchanged |
| Siren, L.L.C. | 892,074 | $6.94M | 0.14% | 00.0% | Unchanged |
| Franklin Resources Inc | 938,666 | $7.23M | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −30,461−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,608−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −10,145−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −10,096−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2,115−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −140−100.0% | Sold out |